NanJing Pharmaceutical Company Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 37,155.742 million compared to CNY 31,303.046 million a year ago. Operating income was CNY 528.723 million compared to CNY 479.731 million a year ago. Net income was CNY 346.920 million compared to CNY 264.293 million a year ago. Basic earnings per share from continuing operations was CNY 0.333 compared to CNY 0.26 a year ago.